Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Gated 99mTc-tetrofosmin and 18F-FDG studies: a comparison of single-acquisition and separate-acquisition protocols.

Pagnanelli RA, Hanson MW, Turkington T, Coleman RE, Borges-Neto S.

J Nucl Med Technol. 2002 Dec;30(4):175-8.

2.

Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.

Matsunari I, Kanayama S, Yoneyama T, Matsudaira M, Nakajima K, Taki J, Nekolla SG, Tonami N, Hisada K.

Eur J Nucl Med Mol Imaging. 2005 Feb;32(2):195-202.

PMID:
15449050
3.

Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging.

Giorgetti A, Marzullo P, Sambuceti G, Di Quirico S, Kusch A, Landi P, Salvadori PA, Pisani P, L'abbate A.

J Nucl Cardiol. 2004 Mar-Apr;11(2):142-51.

PMID:
15052245
4.

Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.

Kam BL, Valkema R, Poldermans D, Bax JJ, Reijs AE, Rambaldi R, Boersma E, Rietveld T, Roelandt JR, Krenning EP.

J Nucl Med. 2003 Feb;44(2):140-5.

5.

Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.

Matsunari I, Kanayama S, Yoneyama T, Matsudaira M, Nakajima K, Taki J, Nekolla SG, Takekoshi N, Tonami N, Hisada K.

Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1357-64.

PMID:
12271419
6.
8.

Comparison of nitrate augmented Tc-99m tetrofosmin gated SPECT imaging with FDG PET imaging for the assessment of myocardial viability in patients with severe left ventricular dysfunction.

Raja S, Singh B, Rohit MK, Manohar K, Kashyap R, Bhattacharya A, Mittal BR.

J Nucl Cardiol. 2012 Dec;19(6):1176-81. doi: 10.1007/s12350-012-9607-9.

PMID:
22872319
9.

Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.

Raja S, Mittal BR, Santhosh S, Bhattacharya A, Rohit MK.

Nucl Med Commun. 2014 Nov;35(11):1156-61. doi: 10.1097/MNM.0000000000000182.

PMID:
25144559
10.

Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.

Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Irwan R, Sluiter WJ, Dierckx RA, de Boer J, Jager PL.

Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):716-23.

PMID:
16523309
11.

Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.

Yoshinaga K, Katoh C, Noriyasu K, Yamada S, Ito Y, Kuge Y, Kawai Y, Kohya T, Kitabatake A, Tamaki N.

Eur J Nucl Med Mol Imaging. 2002 Jul;29(7):882-90.

PMID:
12111128
12.

Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.

Maruyama A, Hasegawa S, Paul AK, Xiuli M, Yoshioka J, Maruyama K, Hori M, Nishimura T.

Ann Nucl Med. 2002 Feb;16(1):25-32.

PMID:
11922205
13.

Estimation of myocardial perfusion and viability using simultaneous 99mTc-tetrofosmin--FDG collimated SPECT.

Fukuchi K, Katafuchi T, Fukushima K, Shimotsu Y, Toba M, Hayashida K, Takamiya M, Ishida Y.

J Nucl Med. 2000 Aug;41(8):1318-23.

14.

Assessment of myocardial viability using F-18 fluorodeoxyglucose/Tc-99m sestamibi dual-isotope simultaneous acquisition SPECT: comparison with Tl-201 stress-reinjection SPECT.

Wu YW, Huang PJ, Lee CM, Ho YL, Lin LC, Wang TD, Wang SS, Chen TH, Yen RF.

J Nucl Cardiol. 2005 Jul-Aug;12(4):451-9.

PMID:
16084434
16.

Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.

Yoshinaga K, Morita K, Yamada S, Komuro K, Katoh C, Ito Y, Kuge Y, Kohya T, Kitabatake A, Tamaki N.

J Nucl Med. 2001 Jun;42(6):838-44.

17.

Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.

Slart RH, Bax JJ, de Boer J, Willemsen AT, Mook PH, Oudkerk M, van der Wall EE, van Veldhuisen DJ, Jager PL.

Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):972-9.

PMID:
15824927
19.

Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability.

Roes SD, Kaandorp TA, Marsan NA, Westenberg JJ, Dibbets-Schneider P, Stokkel MP, Lamb HJ, van der Wall EE, de Roos A, Bax JJ.

Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):594-601. doi: 10.1007/s00259-008-1001-0.

PMID:
19050879
20.

Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT.

Slart RH, Bax JJ, Sluiter WJ, van Veldhuisen DJ, Jager PL.

J Nucl Cardiol. 2004 Nov-Dec;11(6):689-96.

PMID:
15592192

Supplemental Content

Support Center